BRIEF published on 06/09/2026 at 08:05, 1 month 17 days ago Les acteurs du secteur unis pour la sensibilisation à la maladie de Batten Partenariat Étude Clinique Maladie De Batten Sensibilisation THX Pharma
BRIEF published on 06/09/2026 at 08:05, 1 month 17 days ago Industry stakeholders united to raise awareness of Batten disease Partnership Clinical Study Awareness Batten Disease THX Pharma
BRIEF published on 06/09/2026 at 08:04, 1 month 17 days ago Molten Ventures Reports £238m Valuation Uplift Following ICEYE Series F Financing Satellite Technology Molten Ventures Valuation Uplift ICEYE Series F European Tech Investment
BRIEF published on 06/09/2026 at 08:04, 1 month 17 days ago Molten Ventures annonce une valorisation revue à la hausse de 238 millions de livres sterling suite à son financement de série F par ICEYE. Molten Ventures Technologie Satellitaire Revalorisation Série ICEYE F Investissements Technologiques Européens
BRIEF published on 06/09/2026 at 08:00, 1 month 17 days ago Fireaway Receives Certifications for Stat-X Fire-Extinguishing Systems Type Approval Bureau Veritas Stat-X Systems SOLAS Compliance Marine Certification
BRIEF published on 06/09/2026 at 08:00, 1 month 17 days ago Fireaway obtient les certifications pour ses systèmes d'extinction d'incendie Stat-X Homologation De Type Bureau Veritas Systèmes Stat-X Conformité SOLAS Certification Maritime
BRIEF published on 06/09/2026 at 07:54, 1 month 17 days ago K+S Aktiengesellschaft Unveils €300 Million Convertible Bonds Offering Convertible Bonds Institutional Investors K+S Aktiengesellschaft Bond Redemption Salt Business Acquisition
BRIEF published on 06/09/2026 at 07:54, 1 month 17 days ago K+S Aktiengesellschaft dévoile une offre d'obligations convertibles de 300 millions d'euros Obligations Convertibles Investisseurs Institutionnels Rachat D'obligations K+S Aktiengesellschaft Acquisition De Salt Business
BRIEF published on 06/09/2026 at 07:50, 1 month 17 days ago Pentixapharm Holding AG Advances with FDA Approval and Capital Increase Plan FDA Approval Capital Increase Primary Aldosteronism PANDA Study BaFin Review
BRIEF published on 06/09/2026 at 07:50, 1 month 17 days ago Pentixapharm Holding AG franchit une étape importante avec l'approbation de la FDA et son plan d'augmentation de capital Augmentation De Capital Approbation De La FDA Aldostéronisme Primaire Étude PANDA Revue De La BaFin
Published on 07/24/2026 at 23:00, 2 days 2 hours ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 2 days 3 hours ago Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 2 days 3 hours ago Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 2 days 5 hours ago Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Published on 07/26/2026 at 19:12, 6 hours 18 minutes ago EQS-Adhoc: Kapsch TrafficCom reaches agreement with its major financial creditors on key terms of a restructuring.
Published on 07/26/2026 at 18:46, 6 hours 44 minutes ago EQS-Adhoc: Kapsch TrafficCom reaches agreement with its major financial creditors on key terms of a restructuring.
Published on 07/24/2026 at 18:44, 2 days 6 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 18:50, 2 days 6 hours ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 18:50, 2 days 6 hours ago Déclaration hebdomadaire d'opérations effectuées du 20 au 24 juillet 2026
Published on 07/24/2026 at 18:23, 2 days 7 hours ago Communiqué relatif au dépôt d'offre publique de retrait visant les actions Bourrelier Group
